New catheter flush aims to cut infections in kids on IV nutrition
NCT ID NCT04559334
First seen Apr 15, 2026 · Last updated May 21, 2026 · Updated 6 times
Summary
This study tests a daily solution called T-EDTA (Kitelock™) placed into the central lines of children who need IV nutrition. The goal is to prevent blood clots and serious bloodstream infections without damaging the catheter. Up to 15 children aged 3 months to 18 years with a history of clots or infections will receive the solution for up to 12 weeks. The study is currently suspended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION (CLABSI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens's Hospital Boston
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.